Effect of Sulindac and Erlotinib vs Placebo for Colorectal Neoplasia in Familial Adenomatous Polyposis

This secondary analysis of data from the the FAP Erlotinib-Sulindac Trial (FAPEST) trial examines the effect of sulindac and erlotinib on colorectal adenoma formation and regression in patients with familial adenomatous polyposis.

from Cancer via ola Kala on Inoreader http://ift.tt/2nU5KNR
via IFTTT